These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10363646)

  • 21. Ubiquitin, E6-AP, and their role in p53 inactivation.
    Scheffner M
    Pharmacol Ther; 1998 Jun; 78(3):129-39. PubMed ID: 9690814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined Expression of c-jun, c-fos, and p53 Improves Estimation of Prognosis in Oral Squamous Cell Carcinoma.
    Wang S; Xu X; Xu F; Meng Y; Sun C; Shi L; Zhao E
    Cancer Invest; 2016 Sep; 34(8):393-400. PubMed ID: 27558649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential sensitivity of FOS and JUN family members to calpains.
    Carillo S; Pariat M; Steff AM; Roux P; Etienne-Julan M; Lorca T; Piechaczyk M
    Oncogene; 1994 Jun; 9(6):1679-89. PubMed ID: 8183563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective uptake and degradation of c-Fos and v-Fos by rat liver lysosomes.
    Aniento F; Papavassiliou AG; Knecht E; Roche E
    FEBS Lett; 1996 Jul; 390(1):47-52. PubMed ID: 8706827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Degradation mechanism of cell cycle factors by the proteasome].
    Tsurumi C; Shimizu Y; Tanaka K
    Nihon Rinsho; 1996 Mar; 54(3):861-9. PubMed ID: 8904249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts.
    Gentiletti F; Mancini F; D'Angelo M; Sacchi A; Pontecorvi A; Jochemsen AG; Moretti F
    Oncogene; 2002 Jan; 21(6):867-77. PubMed ID: 11840332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ubiquitin-interacting motifs of S5a as a unique upstream inhibitor of the 26S proteasome.
    Elangovan M; Shin DY; Yoo YJ
    Biochem Biophys Res Commun; 2009 Oct; 388(4):723-6. PubMed ID: 19695230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway.
    Brignone C; Bradley KE; Kisselev AF; Grossman SR
    Oncogene; 2004 May; 23(23):4121-9. PubMed ID: 15064742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reconstitution of signal transduction from the membrane to the nucleus in a baculovirus expression system: activation of Raf-1 leads to hypermodification of c-jun and c-fos via multiple pathways.
    Agarwal S; Corbley MJ; Roberts TM
    Oncogene; 1995 Aug; 11(3):427-38. PubMed ID: 7543194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulfur dioxide and benzo(a)pyrene modulates CYP1A and tumor-related gene expression in rat liver.
    Qin G; Meng Z
    Environ Toxicol; 2010 Apr; 25(2):169-79. PubMed ID: 19408242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mos is degraded by the 26S proteasome in a ubiquitin-dependent fashion.
    Ishida N; Tanaka K; Tamura T; Nishizawa M; Okazaki K; Sagata N; Ichihara A
    FEBS Lett; 1993 Jun; 324(3):345-8. PubMed ID: 8405379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chrysotile effects on the expression of anti-oncogene P53 and P16 and oncogene C-jun and C-fos in Wistar rats' lung tissues.
    Cui Y; Wang Y; Deng J; Hu G; Dong F; Zhang Q
    Environ Sci Pollut Res Int; 2018 Aug; 25(23):22378-22388. PubMed ID: 28905283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of p53 stability by Mdm2.
    Kubbutat MH; Jones SN; Vousden KH
    Nature; 1997 May; 387(6630):299-303. PubMed ID: 9153396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased susceptibility to calpains of v-FosFBR but not of v-FosFBJ or v-JunASV17 retroviral proteins compared with their cellular counterparts.
    Steff AM; Carillo S; Pariat M; Piechaczyk M
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):685-92. PubMed ID: 9169601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The sensitivity of c-Jun and c-Fos proteins to calpains depends on conformational determinants of the monomers and not on formation of dimers.
    Pariat M; Salvat C; Bébien M; Brockly F; Altieri E; Carillo S; Jariel-Encontre I; Piechaczyk M
    Biochem J; 2000 Jan; 345 Pt 1(Pt 1):129-38. PubMed ID: 10600648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage.
    Joseph TW; Zaika A; Moll UM
    FASEB J; 2003 Sep; 17(12):1622-30. PubMed ID: 12958168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53.
    Herrmann JL; Briones F; Brisbay S; Logothetis CJ; McDonnell TJ
    Oncogene; 1998 Dec; 17(22):2889-99. PubMed ID: 9879995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deoxycholic acid suppresses p53 by stimulating proteasome-mediated p53 protein degradation.
    Qiao D; Gaitonde SV; Qi W; Martinez JD
    Carcinogenesis; 2001 Jun; 22(6):957-64. PubMed ID: 11375905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitors of transcription, proteasome inhibitors, and DNA-damaging drugs differentially affect feedback of p53 degradation.
    An WG; Chuman Y; Fojo T; Blagosklonny MV
    Exp Cell Res; 1998 Oct; 244(1):54-60. PubMed ID: 9770348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted degradation of c-Fos, but not v-Fos, by a phosphorylation-dependent signal on c-Jun.
    Papavassiliou AG; Treier M; Chavrier C; Bohmann D
    Science; 1992 Dec; 258(5090):1941-4. PubMed ID: 1470918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.